How Biotech Ideas Become Real Patient Impact w/ new co-hosts Alex and Dimitri
About this episode
The episode discusses how biotech innovations reach patients and introduces new co-hosts Alex and Dimitri.
Send us Fan Mail This is the first episode in the rebranded show! Drug and medical device breakthroughs do not reach patients because they’re clever in a lab. They reach patients when innovation, regulatory strategy, partnerships, clinical evidence and commercial reality line up at the same time, and that’s where things get messy. We’re launching Lab to Lives with a simple goal: talk honestly about what slows life sciences down and what actually helps. We start by introducing our new co-host...
More episodes of Lab to Lives
- Why Big Pharma Feels Like A Financial Institution & Don't Pee on Medical Gloves with Anish Shindore
- Dear Pharma, Your Patient Isn’t A KPI with Mark Duman
- Audit Trails, RBQM, And Agentic AI Explained
- Why Bringing The Trial To The Patient Beats Dragging Patients To Sites
- Inside Sionna’s Bid To Normalize CFTR Function
- AI Won’t Replace Writers, But Writers Who Use AI Will Outpace The Rest with Bilal Bham
Explore listener stats, chart rankings, contacts and more on the Lab to Lives podcast page.